Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014927072> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W2014927072 endingPage "S69" @default.
- W2014927072 startingPage "S69" @default.
- W2014927072 abstract "Moderate to severe PHHI usually requires near-total pancreatectomy to avoid hypoglycemia induced brain damage. We treated 13 such patients with octreolide over the last 6 y. Seven subsequently underwent partial pancreatectomy: 2 had inadequate response due to sepsis, 1 failed to respond to combined octreotide/glucagon/diazoxide and 4 because their family situation did not permit chronic octreotide treatment. Data on the remaining 6 pts on chronic octreotide treatment without pancreatectomy are reported here. Frequent feedings with high glucose intake (11-13 mg/kg/min) and raw cornstarch at night were required in all patients, whereas 2 also required gastrostomy due to poor feeding. Octreotide was started immediately in 5 of 6 patients since previous experience indicates that diazoxide is rarely effective in severe disease. Octreotide was given in 3-4 daily sc injections in 3 patients, and continuous sc infusion (Medix insulin infuser) in 3. All patients had acute G1 symptoms (vomiting, abdominal distcntion, steatorrhea) and weight loss after beginning the drug. This responded partially to oral pancreatic enzyme treatment, and remitted after 2-4 weeks. Asymptomatic gallstones were discovered at routine ultrasound in 1 patient after 1 y of treatment. Growth rate decreased in all during the first 2-6 months, but normalized subsequently as did body weight. All patients have normal psychomotor development for age, however 2 are <1 year old. Every 6-12 months an attempt was made to stop octreotide treatment or switch to diazoxide. Five patients stopped octreotide after 8.5 m to 5.5 y; 1 switched to diazoxide (3y), 2 required per-cutaneous gastrostomy, and 1 (5.5 y old) required no further treatment. The remaining 2 (age 4M-1.5y) are still treated with octreotide. We conclude that with octreotide treatment pancreatectomy can be avoided in some patients. However, efficacy is partial, and close follow-up with repeated blood glucose determinations, frequent feedings, gastrostomy and hospital admissions during acute illnesses may still be necessary. Most can eventually stop octreotide and enter complete or partial remission." @default.
- W2014927072 created "2016-06-24" @default.
- W2014927072 creator A5064260585 @default.
- W2014927072 creator A5085234691 @default.
- W2014927072 date "1993-05-01" @default.
- W2014927072 modified "2023-10-18" @default.
- W2014927072 title "PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY (PHHI): PARTIAL AND COMPLETE CLINICAL REMISSION AFTER LONG-TERM OCTREOTIDE TREATMENT" @default.
- W2014927072 doi "https://doi.org/10.1203/00006450-199305001-00397" @default.
- W2014927072 hasPublicationYear "1993" @default.
- W2014927072 type Work @default.
- W2014927072 sameAs 2014927072 @default.
- W2014927072 citedByCount "0" @default.
- W2014927072 crossrefType "journal-article" @default.
- W2014927072 hasAuthorship W2014927072A5064260585 @default.
- W2014927072 hasAuthorship W2014927072A5085234691 @default.
- W2014927072 hasBestOaLocation W20149270721 @default.
- W2014927072 hasConcept C126322002 @default.
- W2014927072 hasConcept C141071460 @default.
- W2014927072 hasConcept C2775858560 @default.
- W2014927072 hasConcept C2776230353 @default.
- W2014927072 hasConcept C2776297358 @default.
- W2014927072 hasConcept C2777675875 @default.
- W2014927072 hasConcept C2778494859 @default.
- W2014927072 hasConcept C2778764654 @default.
- W2014927072 hasConcept C2779306644 @default.
- W2014927072 hasConcept C2779872217 @default.
- W2014927072 hasConcept C2780053029 @default.
- W2014927072 hasConcept C2780668416 @default.
- W2014927072 hasConcept C2781025020 @default.
- W2014927072 hasConcept C71924100 @default.
- W2014927072 hasConcept C90924648 @default.
- W2014927072 hasConceptScore W2014927072C126322002 @default.
- W2014927072 hasConceptScore W2014927072C141071460 @default.
- W2014927072 hasConceptScore W2014927072C2775858560 @default.
- W2014927072 hasConceptScore W2014927072C2776230353 @default.
- W2014927072 hasConceptScore W2014927072C2776297358 @default.
- W2014927072 hasConceptScore W2014927072C2777675875 @default.
- W2014927072 hasConceptScore W2014927072C2778494859 @default.
- W2014927072 hasConceptScore W2014927072C2778764654 @default.
- W2014927072 hasConceptScore W2014927072C2779306644 @default.
- W2014927072 hasConceptScore W2014927072C2779872217 @default.
- W2014927072 hasConceptScore W2014927072C2780053029 @default.
- W2014927072 hasConceptScore W2014927072C2780668416 @default.
- W2014927072 hasConceptScore W2014927072C2781025020 @default.
- W2014927072 hasConceptScore W2014927072C71924100 @default.
- W2014927072 hasConceptScore W2014927072C90924648 @default.
- W2014927072 hasLocation W20149270721 @default.
- W2014927072 hasOpenAccess W2014927072 @default.
- W2014927072 hasPrimaryLocation W20149270721 @default.
- W2014927072 hasRelatedWork W1911314772 @default.
- W2014927072 hasRelatedWork W1937219258 @default.
- W2014927072 hasRelatedWork W2014927072 @default.
- W2014927072 hasRelatedWork W2030302555 @default.
- W2014927072 hasRelatedWork W2085551194 @default.
- W2014927072 hasRelatedWork W2090030914 @default.
- W2014927072 hasRelatedWork W2251658339 @default.
- W2014927072 hasRelatedWork W2313558530 @default.
- W2014927072 hasRelatedWork W2612069122 @default.
- W2014927072 hasRelatedWork W2907579143 @default.
- W2014927072 hasVolume "33" @default.
- W2014927072 isParatext "false" @default.
- W2014927072 isRetracted "false" @default.
- W2014927072 magId "2014927072" @default.
- W2014927072 workType "article" @default.